<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome) - da Silva, EMK - 2016 | Cochrane Library</title> <meta content="Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome) - da Silva, EMK - 2016 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008185.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome) - da Silva, EMK - 2016 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008185.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD008185.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome)" name="citation_title"/> <meta content="Edina MK da Silva" name="citation_author"/> <meta content="Universidade Federal de São Paulo" name="citation_author_institution"/> <meta content="edinaksilva@terra.com.br" name="citation_author_email"/> <meta content="Maria Wany Louzada Strufaldi" name="citation_author"/> <meta content="Universidade Federal de São Paulo" name="citation_author_institution"/> <meta content="Regis B Andriolo" name="citation_author"/> <meta content="Universidade do Estado do Pará" name="citation_author_institution"/> <meta content="Laercio A Silva" name="citation_author"/> <meta content="Universidade Federal de São Paulo" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="2" name="citation_issue"/> <meta content="10.1002/14651858.CD008185.pub4" name="citation_doi"/> <meta content="2016" name="citation_date"/> <meta content="2016/02/05" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008185.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008185.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008185.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Drug Administration Schedule; Enzyme Replacement Therapy [*methods]; Iduronate Sulfatase [*administration &amp; dosage]; Mucopolysaccharidosis II [*drug therapy]; Randomized Controlled Trials as Topic; Rare Diseases [*drug therapy, enzymology]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008185.pub4&amp;doi=10.1002/14651858.CD008185.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008185.pub4&amp;doi=10.1002/14651858.CD008185.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008185.pub4&amp;doi=10.1002/14651858.CD008185.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008185.pub4&amp;doi=10.1002/14651858.CD008185.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008185.pub4&amp;doi=10.1002/14651858.CD008185.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008185.pub4&amp;doi=10.1002/14651858.CD008185.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008185.pub4&amp;doi=10.1002/14651858.CD008185.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008185.pub4&amp;doi=10.1002/14651858.CD008185.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008185.pub4&amp;doi=10.1002/14651858.CD008185.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008185.pub4&amp;doi=10.1002/14651858.CD008185.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008185.pub4&amp;doi=10.1002/14651858.CD008185.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008185.pub4&amp;doi=10.1002/14651858.CD008185.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008185.pub4&amp;doi=10.1002/14651858.CD008185.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008185.pub4&amp;doi=10.1002/14651858.CD008185.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008185.pub4&amp;doi=10.1002/14651858.CD008185.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008185.pub4&amp;doi=10.1002/14651858.CD008185.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008185.pub4&amp;doi=10.1002/14651858.CD008185.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008185.pub4&amp;doi=10.1002/14651858.CD008185.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008185.pub4&amp;doi=10.1002/14651858.CD008185.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008185.pub4&amp;doi=10.1002/14651858.CD008185.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008185.pub4&amp;doi=10.1002/14651858.CD008185.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008185.pub4&amp;doi=10.1002/14651858.CD008185.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008185.pub4&amp;doi=10.1002/14651858.CD008185.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="VXKc2U6b";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD008185\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD008185\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008185\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008185\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","hr","ms","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD008185.pub4",title:"Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome)",firstPublishedDate:"Feb 5, 2016 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Cystic Fibrosis and Genetic Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=VXKc2U6b&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008185.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD008185.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD008185.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD008185.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008185.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD008185.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD008185.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD008185.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD008185.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD008185.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2282 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD008185.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008185.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008185.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008185.pub4/full#CD008185-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008185.pub4/full#CD008185-sec-0090"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008185.pub4/full#CD008185-sec-0015"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008185.pub4/full#CD008185-sec-0020"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008185.pub4/full#CD008185-sec-0021"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008185.pub4/full#CD008185-sec-0046"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008185.pub4/full#CD008185-sec-0085"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008185.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008185.pub4/appendices#CD008185-sec-0095"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008185.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008185.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/table_n/CD008185StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/table_n/CD008185StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008185.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008185.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008185.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD008185.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD008185.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD008185.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome) </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008185.pub4/information#CD008185-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Edina MK da Silva</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008185.pub4/information#CD008185-cr-0003">Maria Wany Louzada Strufaldi</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008185.pub4/information#CD008185-cr-0004">Regis B Andriolo</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008185.pub4/information#CD008185-cr-0005">Laercio A Silva</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/information/en#CD008185-sec-0102">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 05 February 2016 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD008185.pub4">https://doi.org/10.1002/14651858.CD008185.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD008185-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008185-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008185-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD008185-abs-0007">فارسی</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD008185-abs-0001" lang="en"> <section id="CD008185-sec-0001"> <h3 class="title" id="CD008185-sec-0001">Background</h3> <p>Mucopolysaccharidosis II, also known as Hunter syndrome, is a rare, X‐linked disease caused by a deficiency of the lysosomal enzyme iduronate‐2‐sulfatase, which catalyses a step in the catabolism of glycosaminoglycans. The glycosaminoglycans accumulate within tissues affecting multiple organs and physiologic systems. The clinical manifestations include neurologic involvement, severe airways obstruction, skeletal deformities and cardiomyopathy. The disease has a variable age of onset and variable rate of progression. In those with severe disease, death usually occurs in the second decade of life, whereas those individuals with less severe disease may survive into adulthood. Enzyme replacement therapy with intravenous infusions of idursulfase has emerged as a new treatment for mucopolysaccharidosis type II. This is an update of a previously published version of this review. </p> </section> <section id="CD008185-sec-0002"> <h3 class="title" id="CD008185-sec-0002">Objectives</h3> <p>To evaluate the effectiveness and safety of enzyme replacement therapy with idursulfase compared to other interventions, placebo or no intervention, for treating mucopolysaccharidosis type II. </p> </section> <section id="CD008185-sec-0003"> <h3 class="title" id="CD008185-sec-0003">Search methods</h3> <p>We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group's Trials Register (date of last search 23 November 2015). </p> <p>We also searched Embase, PubMed and the Literature Latino‐Americana e do Caribe em Ciências da Saúde (LILACS) (date of last search 28 November 2015). </p> </section> <section id="CD008185-sec-0004"> <h3 class="title" id="CD008185-sec-0004">Selection criteria</h3> <p>Randomised and quasi‐randomised controlled trials of enzyme replacement therapy with idursulfase compared to no intervention, placebo or other options (e.g. behavioral strategies, transplantation). </p> </section> <section id="CD008185-sec-0005"> <h3 class="title" id="CD008185-sec-0005">Data collection and analysis</h3> <p>Two authors independently screened the trials identified, appraised quality of papers and extracted data. </p> </section> <section id="CD008185-sec-0006"> <h3 class="title" id="CD008185-sec-0006">Main results</h3> <p>One study (96 male participants) met the inclusion criteria, although the primary outcome of this review ‐ z score for height and weight, was not assessed in the study. This trial was considered to be of overall good quality. Following 53 weeks of treatment, participants in the weekly idursulfase 0.5 mg/kg group demonstrated a significant improvement rate compared with placebo for the primary outcome: distance walked in six minutes on the basis of the sum of ranks of change from baseline, mean difference 37.00 (95% confidence interval 6.52 to 67.48). The every‐other‐week idursulfase 0.5 mg/kg group also showed an improvement, which was not significant compared with placebo, mean difference 23.00 (95% confidence interval ‐4.49 to 50.49). After 53 weeks, there was no statistical significance difference in per cent predicted forced vital capacity between the three groups and absolute forced vital capacity was significantly increased from baseline in the weekly dosing group compared to placebo, mean difference 0.16 (95% confidence interval CI 0.05 to 0.27). No difference was observed between the every‐other‐week idursulfase 0.5 mg/kg group and placebo. </p> <p>In addition, liver and spleen volumes and urine glycosaminoglycan excretion were significantly reduced from baseline by both idursulfase dosing regimens. Idursulfase was generally well tolerated, but infusion reactions did occur. Idursulfase antibodies were detected in 31.7% of participants at the end of the study and they were related to a smaller reduction in urine glycosaminoglycan levels. </p> </section> <section id="CD008185-sec-0007"> <h3 class="title" id="CD008185-sec-0007">Authors' conclusions</h3> <p>The current evidence is limited. While the randomised clinical trial identified was considered to be of good quality, it failed to describe important outcomes. It has been demonstrated that enzyme replacement therapy with idursulfase is effective in relation to functional capacity (distance walked in six minutes and forced vital capacity), liver and spleen volumes and urine glycosaminoglycan excretion in people with mucopolysaccharidosis type II compared with placebo. There is no available evidence in the included study and in the literature on outcomes such as improvement in growth, sleep apnoea, cardiac function, quality of life and mortality. More studies are needed to obtain more information on the long‐term effectiveness and safety of enzyme replacement therapy. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD008185-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008185-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008185-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD008185-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD008185-abs-0004">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD008185-abs-0006">Bahasa Malaysia</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD008185-abs-0003" lang="en"> <h3>Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome) </h3> <p><b>Review question</b> </p> <p>We reviewed the evidence about the effect and safety of enzyme replacement therapy with idursulfase compared to other interventions, placebo ('dummy treatment') or no intervention, for treating people with mucopolysaccharidosis type II. This is an update of a previously published version of this review. </p> <p><b>Background</b> </p> <p>Hunter syndrome or mucopolysaccharidosis II is a rare genetic disease that occurs when an enzyme that the body needs is either missing or malfunctioning. The body doesn't have adequate supplies of this enzyme to break down certain complex molecules, so these molecules build up in harmful amounts in certain cells and tissues. The build‐up that occurs in Hunter syndrome eventually causes permanent, progressive damage affecting appearance, mental development, organ function and physical abilities. Hunter syndrome appears in children as young as the age of two years and it nearly always occurs in males. In the past, treatment of Hunter syndrome has been limited to the relief of symptoms and complications. Enzyme replacement therapy with idursulfase aims to replace iduronate‐2‐sulfatase, the enzyme that is deficient or absent in people with Hunter syndrome. However, given its high cost it is essential to assess how effective and safe this treatment is. </p> <p><b>Search date</b> </p> <p>The evidence is current to: 23 November 2015.</p> <p><b>Study characteristics</b> </p> <p>The review included one study with 96 males with Hunter syndrome aged between 4.9 and 30.9 years of age. The trial compared idursulfase 0.5 mg/kg given either weekly or every‐other week, or weekly infusions of placebo (a substance which contains no medication) and people were selected for one treatment or the other randomly. The study lasted 53 weeks. </p> <p><b>Key results</b> </p> <p>Current evidence is limited given there was only one randomised clinical trial found in the medical literature. As compared with placebo, enzyme replacement therapy with idursulfase in people with Hunter syndrome, led to some improvement in the individuals' ability to walk and a reduction in the excretion of abnormal mucopolysaccharides in the urine. To date there is no evidence available in the literature showing that treatment reduces complications of the disease related to quality of life and mortality. </p> <p><b>Quality of the evidence</b> </p> <p>This trial was considered to be of overall good quality.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD008185-sec-0090" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD008185-sec-0090"></div> <h3 class="title" id="CD008185-sec-0091">Implications for practice</h3> <section id="CD008185-sec-0091"> <p>The current evidence is limited. While the randomised clinical trial identified was considered of good quality, it failed to describe important outcomes. It has been demonstrated that enzyme replacement therapy with idursulfase is effective in relation to functional capacity (6MWT and per cent predicted FVC), liver and spleen volumes and urine GAG excretion in people with MPS II compared with placebo. There is no available evidence in the included study or in the wider literature on outcomes such as sleep apnoea, cardiac function, quality of life and mortality. More studies are needed to obtain more information on the long‐term effectiveness and safety of enzyme replacement therapy. </p> </section> <h3 class="title" id="CD008185-sec-0092">Implications for research</h3> <section id="CD008185-sec-0092"> <p>Further trials, including rigorous multi‐domain follow up of participants receiving treatment, are needed to determine the long‐term effects of enzyme replacement therapy. Clinically relevant outcomes should be assessed, such as improvements in cardiac function, respiratory function, including sleep apnoea, stabilization of skeletal abnormality, quality of life, need of hospitalizations and mortality. The effects of immunogenicity on the safety and effectiveness of enzyme replacement therapy with idursulfase need to be better studied. </p> <p>The effects of enzyme replacement therapy with idursulfase in children under five years of age need to be further investigated, given that the early introduction of therapy with consequent limitation of the formation of lysosomal storage can potentially lead to better outcomes in the evolution of the disease. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD008185-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD008185-sec-0015"></div> <section id="CD008185-sec-0016"> <h3 class="title" id="CD008185-sec-0016">Description of the condition</h3> <p>Mucopolysaccharidosis II (MPS II or Hunter syndrome) belongs to a group of inherited diseases of glycosaminoglycan (GAG) catabolism called mucopolysaccharidoses. The GAGs are oligosaccharide components of the proteoglycans, macromolecules responsible for the integrity and function of connective tissue. Mucopolysaccharidoses are caused by a lysosomal enzyme deficiency for the stepwise degradation of the GAGs. All of the mucopolysaccharidoses are of recessive autosome inheritance<b>,</b> except MPS II, which is an X‐linked recessive disease. The syndrome was described by Charles Hunter in 1917 and is the result of a deficiency of iduronate‐2‐sulfatase (I2S), with consequent increase of the urinary concentration of the GAGs dermatan sulphate and heparan sulphate. The clinical phenotype of MPS II is characterised by progressive pathological lysosomal storage of GAGs in nearly all cell types, tissues and organs. The iduronate 2‐sulfatase gene is located on chromosome Xq28, and more than 350 mutations have been identified to date, including different deletions, splice‐site and point mutations. This genetic heterogeneity may explain the high degree of clinical heterogeneity in MPS II (<a href="./references#CD008185-bbs2-0019" title="MartinR , BeckM , EngC , GiuglianiR , HarmatzP , MunozV , et al. Recognition and Diagnosis of Mucopolysaccharidosis II (Hunter Syndrome). Pediatrics2008;121(2):e377‐86. ">Martin 2008</a>; <a href="./references#CD008185-bbs2-0027" title="WraithJE , ScarpaM , BeckM , BodamerOA , DeMeirleirL , GuffonN , et al. Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. European Journal of Pediatrics2008;167(3):267‐77. ">Wraith 2008a</a>). </p> <p>This is a rare disease with an estimated incidence of approximately 1 in 162,000 live births. Although males are predominantly affected, a small number of affected females have been described (<a href="./references#CD008185-bbs2-0020" title="MeiklePJ , HopwoodJJ , ClagueAE , CareyWF . Prevalence of lysosomal storage disorders. JAMA1999;281(3):249‐54. ">Meikle 1999</a>; <a href="./references#CD008185-bbs2-0025" title="TuschlK , GalA , PaschkeE , KircherS , BodamerOA .  Mucopolysaccharidosis type II in females: case report and review of literature. Pediatric Neurology2005;32(4):270‐2. ">Tuschl 2005</a>). This is a variable, progressive, multisystem disease and should be regarded as a continuum between two extremes (severe and attenuated). Two‐thirds of individuals present central nervous system (CNS) involvement, representing the more severe form, with clinical features appearing between two and four years of age. In these cases, the progressive neurologic involvement is prominent and leads to severe mental impairment; death usually occurs in the first or second decade of life, usually because of obstructive airway disease or cardiac failure (or both) associated with loss of neurologic function. At the opposite end of the spectrum, clinical signs and symptoms have a slightly later onset and the neurologic dysfunction may be minimal, but with obvious somatic involvement, and longer survival (<a href="./references#CD008185-bbs2-0027" title="WraithJE , ScarpaM , BeckM , BodamerOA , DeMeirleirL , GuffonN , et al. Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. European Journal of Pediatrics2008;167(3):267‐77. ">Wraith 2008a</a>). Data from the 'Hunter Outcome Survey' (HOS), the only large‐scale, multinational observational study of people with MPS II, showed that median age at death was significantly lower in those with cognitive involvement compared with those without cognitive involvement (11.7 versus 14.1 years; P = 0.024) (<a href="./references#CD008185-bbs2-0016" title="JonesSA , AlmássyZ , BeckM , BurtK , ClarkeJT , GiuglianiR , et al. Mortality and cause of death in mucopolysaccharidosis type II‐a historical review based on data from the Hunter Outcome Survey (HOS). Journal of Inherited Metabolic Disease2008;32(4):534‐43. ">Jones 2008</a>). </p> <p>The most common clinical signs and symptoms include dysostosis multiplex with decreased range of joint motion, coarse facial features, enlarged tongue, hearing loss, abnormal dentition, upper airway obstruction with or without sleep apnoea, restrictive lung disease, hepatosplenomegaly, cardiomyopathy, skeletal deformities, and severe short stature (<a href="./references#CD008185-bbs2-0029" title="YoungID , HarperPS . The natural history of the severe form of Hunter's syndrome: a study based on 52 cases. Developmental Medicine and Child Neurology1983;25(4):481‐9. ">Young 1983</a>).  </p> <p>The development of children with MPS II seems normal in the first months of life, but the outcome is highly changeable. Even in individuals with attenuated disease, cranial magnetic resonance imaging (MRI) scans are often grossly abnormal, with extensive white matter changes as well as dilated perivascular spaces, despite apparently normal intellectual skills. Individuals with more severe MPS II also appear normal at birth, and early development may be normal. Some individuals fail hearing screening tests in the first year, and speech delay is not unusual in those more severely affected. By 18 to 24 months developmental delay is usually apparent. Most individuals make very slow progress after this stage, with a developmental plateau beginning between three and five years of age. Unlike children with severe MPS I, who are usually placid, more severely affected children with MPS II can be hyperactive and aggressive. One of the most important limitations beside the neurologic involvement in individuals suffering from MPS II, is the impact that the progressive physical abnormalities have on their quality of life. Due to a combination of the bone disease, decreased respiratory capacity and impaired cardiac function, they suffer from chronic, severely diminished endurance. With the disease progression their ability to walk even short distances may be lost and eventually many people become wheelchair‐bound. By the time of death in their second decade, most individuals with CNS involvement show severe learning difficulties and are dependant on care providers for all their needs (<a href="./references#CD008185-bbs2-0027" title="WraithJE , ScarpaM , BeckM , BodamerOA , DeMeirleirL , GuffonN , et al. Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. European Journal of Pediatrics2008;167(3):267‐77. ">Wraith 2008a</a>).  </p> <p>The measurement of urinary GAGs (heparan and dermatan sulphate) is the usual first screening test for MPS II. As in almost all cases of MPS, the total urinary GAG level is increased. However, this is not diagnostic of MPS II, so additional tests must be performed. Futhermore, a negative urine GAG test does not necessarily rule out a diagnosis of MPS II, because false‐negative results can occur as a result of a lack of sensitivity of the testing method (<a href="./references#CD008185-bbs2-0011" title="deJongJG , WeversRA , Liebrand‐van SambeekR . Measuring urinary glycosaminoglycans in the presence of protein: an improved screening procedure for mucopolysaccharidoses based on dimethylmethylene blue. Clinical Chemistry1992;38(6):803‐7. ">de Jong 1992</a>). Definitive diagnosis is established by enzyme assay in leukocytes, fibroblasts or plasma, using substrates specific for I2S. Absent or low I2S activity in males is diagnostic of MPS II, provided that multiple sulphatase deficiency is excluded by finding normal activity of another sulphatase. Absolute enzyme activity cannot be used to predict the severity of the phenotype. Mutation analysis may be used to confirm Hunter syndrome in males. However, it is difficult to establish a genotype‐phenotype correlation to provide an indication of the likely prognosis, this is because individuals carrying the same alterations may present different phenotypes, suggesting that others factors may modulate the clinical phenotype (<a href="./references#CD008185-bbs2-0018" title="KresseH , vonFiguraK , KleinU , GlosslJ , PaschkeE , PohlmannR . Enzymic diagnosis of the genetic mucopolysaccharide storage disorders. Methods in Enzymology1982;83:559‐72. ">Kresse 1982</a>;<a href="./references#CD008185-bbs2-0019" title="MartinR , BeckM , EngC , GiuglianiR , HarmatzP , MunozV , et al. Recognition and Diagnosis of Mucopolysaccharidosis II (Hunter Syndrome). Pediatrics2008;121(2):e377‐86. ">Martin 2008</a>; <a href="./references#CD008185-bbs2-0023" title="NeufeldEF , MuenzerJ . The mucopolysaccharidoses. The Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw‐Hill, 2001:3421‐52. ">Neufeld 2001</a>). </p> <p>As the definition of effective treatment for MPS II is "an improvement in or a prevention of progression of disease activity as indicated by a stabilisation in clinical condition associated with an improvement in the abnormalities present at baseline" (<a href="./references#CD008185-bbs2-0026" title="VellodiA , WraithJE , ClearyM , RamaswamiU , LaveryC , JessopE . Guidelines for the investigation and management of patients with mucopolysaccharidosis type II. www.specialisedservices.nhs.uk/library/23/Guidelines_for_Mucopolysaccharidosis_Type_II.pdf(accessed September 2009). ">Vellodi 2007</a>), the primary endpoints for the evaluation of interventions for the treatment of this condition should reflect improvement in important signs and symptoms observed in the disease, such as a change in the speed of growth and in the impairment of cardiac and respiratory system. </p> <p>The usual management of MPS II has been palliative and focused on the treatment of signs and symptoms. Care for the person with MPS II involves a multidisciplinary approach and includes paediatricians, neurologists, orthopedists, otolaryngologists, ophthalmologists, and occupational and physical therapists, as well as geneticists and counsellors (<a href="./references#CD008185-bbs2-0022" title="National Horizon Scanning Centre. New and Emerging Technology Briefing: Iduronate‐2‐sulfatase for Hunter Syndrome. The University of Birmingham2005. ">National Horizon Scanning Centre 2005</a>). Hemapoietic stem cell transplantation (HSCT) by bone marrow transplantation, human amnion membrane implantation, fibroblast transplantation, serum or plasma infusion has been suggested as a means of providing donor cells capable of expressing I2S, but the results are disappointing and long‐term outcomes are limited, therefore, HSCT is not currently recommended for individuals with MPS II (<a href="./references#CD008185-bbs2-0019" title="MartinR , BeckM , EngC , GiuglianiR , HarmatzP , MunozV , et al. Recognition and Diagnosis of Mucopolysaccharidosis II (Hunter Syndrome). Pediatrics2008;121(2):e377‐86. ">Martin 2008</a>). </p> </section> <section id="CD008185-sec-0017"> <h3 class="title" id="CD008185-sec-0017">Description of the intervention</h3> <p>Recently idursulfase (Elaprase<sup>®</sup>, Shire Human Genetic Therapies, Inc, Cambridge, MA), a recombinant human I2S produced in a human cell line, was approved in the United States of America and the European Union for the treatment of MPS II. </p> </section> <section id="CD008185-sec-0018"> <h3 class="title" id="CD008185-sec-0018">How the intervention might work</h3> <p>The rationale for therapy is that exogenous I2S would replace the I2S that is deficient in people with MPS II and either stop or reverse disease progression. Idursulfase is produced in a continuous human cell line and is a purified form of the natural lysosomal enzyme I2S. Mannose‐6‐phosphate (M6P) residues on the oligosaccharide chains of the glycoprotein enzyme and allows specific binding of idursulfase to M6P receptors on the cell surface, leading to cellular internalisation and targeting of the enzyme to lysosomes, and subsequent catabolism of accumulated GAGs (<a href="./references#CD008185-bbs2-0028" title="WraithJE . Enzyme replacement therapy with idursulfase in patients with mucopolysaccharidosis type II. Acta Paediatrica. Supplementum2008;97(497):76‐8. ">Wraith 2008b</a>). </p> </section> <section id="CD008185-sec-0019"> <h3 class="title" id="CD008185-sec-0019">Why it is important to do this review</h3> <p>There is no definitive treatment for people diagnosed with MPS II. The appearance of a promising therapeutic strategy, idursulfase, makes it necessary to map the knowledge in this area based on the rigor inherent to systematic reviews by considering relevant aspects of the effectiveness and safety of this therapeutic strategy for relevant clinical issues. </p> <p>The current publication is a minor update of a Cochrane review first published in 2011 and again in 2014 (<a href="./references#CD008185-bbs2-0030" title="daSilvaEMK , daSilvaEMK , StrufaldiMWL , AndrioloRB , SilvaLA . Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome). Cochrane Database of Systematic Reviews2011, Issue 11. [DOI: 10.1002/14651858.CD008185.pub2] ">da Silva 2011</a>; <a href="./references#CD008185-bbs2-0031" title="daSilvaEMK , StrufaldiMWL , AndrioloRB , SilvaLA . Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome). Cochrane Database of Systematic Reviews2014, Issue 1. [DOI: 10.1002/14651858.CD008185.pub3] ">da Silva 2014</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD008185-sec-0020" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD008185-sec-0020"></div> <p>To evaluate the effectiveness and safety of enzyme replacement therapy with idursulfase compared to other interventions, placebo or no intervention, for treating mucopolysaccharidosis type II. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD008185-sec-0021" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD008185-sec-0021"></div> <section id="CD008185-sec-0022"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD008185-sec-0023"> <h4 class="title">Types of studies</h4> <p>Randomised and quasi‐randomised controlled clinical trials of parallel or cross‐over design. </p> </section> <section id="CD008185-sec-0024"> <h4 class="title">Types of participants</h4> <p>Individuals with MPS II (Hunter syndrome) of any age and any degree of disease severity. Diagnosis should be established by enzyme assay in leukocytes, fibroblasts or plasma, using substrates specific for I2S. </p> </section> <section id="CD008185-sec-0025"> <h4 class="title">Types of interventions</h4> <p>Enzyme replacement therapy with idursulfase in any amount given for a period of at least one month compared to: </p> <p> <ul id="CD008185-list-0001"> <li> <p>no intervention;</p> </li> <li> <p>placebo;</p> </li> <li> <p>other options (e.g. behavioral strategies, transplantation).</p> </li> </ul> </p> </section> <section id="CD008185-sec-0026"> <h4 class="title">Types of outcome measures</h4> <p>Following further advice from the Cochrane Cystic Fibrosis and Genetic Disorders Editorial Team, we have made <i>post hoc</i> changes to the outcomes. Previously listed as primary outcomes ‐ 'left ventricular mass index' and 'overnight apnoea‐hypopnoea index (AHI)' have been re‐allocated to secondary outcomes. The six‐minute walk test (6MWT) has been re‐allocated from secondary outcomes to primary outcomes. Given that MPS II is a disease with multiorgan and multisystem involvement, a variable age of onset and a variable rate of progression, we found the choice of representative outcomes a challenge. Since appropriate growth is a key clinical feature in children and this is altered in all forms of MPS II, we selected z score of weight and height as the primary outcome (<a href="./references#CD008185-bbs2-0019" title="MartinR , BeckM , EngC , GiuglianiR , HarmatzP , MunozV , et al. Recognition and Diagnosis of Mucopolysaccharidosis II (Hunter Syndrome). Pediatrics2008;121(2):e377‐86. ">Martin 2008</a>; <a href="./references#CD008185-bbs2-0027" title="WraithJE , ScarpaM , BeckM , BodamerOA , DeMeirleirL , GuffonN , et al. Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. European Journal of Pediatrics2008;167(3):267‐77. ">Wraith 2008a</a>). As studies may include adults, the functional capacity test 6MWT was also selected as a primary outcome because this standardized test is the most often used to measure functional capacity (<a href="./references#CD008185-bbs2-0010" title="American Thoracic Society. ATS statement: guidelines for the six‐minute walk test. American Journal of Respiratory and Critical Care Medicine2002;166(1):111‐7. ">ATS 2002</a>). Outcomes that represent changes in other organs and systems are listed as secondary. </p> <section id="CD008185-sec-0027"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD008185-list-0002"> <li> <p>Z scores for</p> <ol id="CD008185-list-0003"> <li> <p>height</p> </li> <li> <p>weight</p> </li> </ol> </li> <li> <p>Six‐minute walk test (6MWT)</p> </li> </ol> </p> </section> <section id="CD008185-sec-0028"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD008185-list-0004"> <li> <p>Lung function</p> <ol id="CD008185-list-0005"> <li> <p>forced expiratory volume at one second (FEV<sub>1</sub>) </p> </li> <li> <p>forced vital capacity (FVC)</p> </li> <li> <p>any other measure of lung function (e.g. Rint)</p> </li> </ol> </li> <li> <p>Overnight apnoea‐hypopnoea index (AHI)</p> </li> <li> <p>Left ventricular mass index</p> </li> <li> <p>Joint mobility score (using a validated scoring system)</p> </li> <li> <p>Liver and spleen volume (measured by abdominal MRI)</p> </li> <li> <p>Quality of life (using a validated scoring system)</p> </li> <li> <p>Pain (using a validated scoring system e.g. visual analogue scales (VAS))</p> </li> <li> <p>Rate of hospitalizations</p> </li> <li> <p>Resources required for home care support</p> </li> <li> <p>Changes in glycosaminoglycans (GAGs) urinary excretion</p> </li> <li> <p>Developmental score</p> </li> <li> <p>Audiologic assessment (e.g. pure tone audiogram, distortion product otoacoustic emission (DPOE), evoked responses) </p> </li> <li> <p>Age at death</p> </li> <li> <p>Adverse effects (AE) and toxicity of treatment</p> </li> </ol> </p> </section> </section> </section> <section id="CD008185-sec-0029"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD008185-sec-0030"> <h4 class="title">Electronic searches</h4> <p>There was no language restriction and the trials were identified from the sources listed below. </p> <p>We identified relevant trials from the Cochrane Cystic Fibrosis and Genetic Disorders Group's Inborn Errors of Metabolism Trials Register using the term: mucopolysaccharidosis. </p> <p>This register was compiled from electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL) (updated each new issue of <i>The Cochrane Library</i> ), weekly searches of MEDLINE and the prospective handsearching of the <i>Journal of Inherited Metabolic Disease</i>. Unpublished work were identified by searching through the abstract books of the Society for the Study of Inborn Errors of Metabolism conference and the SHS Inborn Error Review Series. For full details of all searching activities for the register, please see the relevant section of the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/CF/frame.html" target="_blank">Cystic Fibrosis and Genetic Disorders Group Module</a>. </p> <p>We also searched Embase (1980 to 23 November 2015), PubMed (1980 to 23 November 2015) and the Literature Latino‐Americana e do Caribe em Ciências da Saúde ‐ LILACS (1982 to 23 November 2015). The search strategy was composed of the terms 'enzyme replacement therapy' and 'Mucopolysaccharidosis II'. We searched with both, subject headings and free text words (<i>see</i><a href="./appendices#CD008185-sec-0096">Appendix 1</a>; <a href="./appendices#CD008185-sec-0097">Appendix 2</a>; <a href="./appendices#CD008185-sec-0098">Appendix 3</a>). </p> <p>Date of most recent search of the Cochrane Cystic Fibrosis and Genetic Disorders Group's Inborn Errors of Metabolism Trials Register: 23 November 2015. </p> </section> <section id="CD008185-sec-0031"> <h4 class="title">Searching other resources</h4> <p>Reference lists of any identified relevant studies were scrutinized for additional citations. </p> </section> </section> <section id="CD008185-sec-0032"> <h3 class="title" id="CD008185-sec-0032">Data collection and analysis</h3> <section id="CD008185-sec-0033"> <h4 class="title">Selection of studies</h4> <p>Two authors (EMKS and LAS) independently screened the studies identified by the literature search. When disagreements occurred they consulted a third author (RBA) and did not include data until they reached a consensus. </p> </section> <section id="CD008185-sec-0034"> <h4 class="title">Data extraction and management</h4> <p>Two authors (EMKS and LAS) extracted data independently; they resolved discrepancies in the results by discussion. The authors used a standard form to extract the following information: characteristics of the study (design, method of randomisation); participants; interventions; and outcomes (types of outcome measures, timing of outcomes, adverse events). </p> <p>The authors planned to report outcomes at up to and including three months, over three months and up to six months, over six months and up to twelve months and then annually thereafter. They also planned to consider additional follow‐up data recorded at more than 12 months. Given only one trial is currently included they have reported these data at 53 weeks, as within the trial. </p> <p>The included trial reported standard errors (SE) ; the authors converted these to standard deviations (SD) (SD = SE x  square root of n). </p> </section> <section id="CD008185-sec-0035"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>In order to assess the risk of bias, two review authors independently assessed the quality of the studies included in the review according to the criteria described in the <i>Cochrane Handbook For Systemtic Review of Interventions</i> (<a href="./references#CD008185-bbs2-0014" title="HigginsJPT , AltmanDG . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011a</a>). </p> <p>They assessed the following domains as having either a low, unclear or high risk of bias. </p> <p> <ol id="CD008185-list-0006"> <li> <p>Was the sequence generation adequate?</p> </li> <li> <p>Was allocation adequately concealed?</p> </li> <li> <p>Was knowledge of the allocated interventions adequately prevented during the study?</p> </li> <li> <p>Were incomplete outcome data adequately addressed?</p> </li> <li> <p>Are reports of the study free of suggestion of selective outcome reporting?</p> </li> <li> <p>Was the study apparently free of other problems that could put it at a high risk of bias? </p> </li> </ol> </p> <p>The authors reported these assessments for each individual study in the 'Risk of bias' table in the section '<a href="./references#CD008185-sec-0108" title="">Characteristics of included studies</a>'. </p> <p>If necessary, for future updates, they plan to contact the study author(s) to seek clarification in case of uncertainty over data. </p> </section> <section id="CD008185-sec-0036"> <h4 class="title">Measures of treatment effect</h4> <p>For dichotomous variables, the authors calculated the risk ratio (RR) and 95% confidence intervals (CIs). For continuous outcomes, they calculated the mean difference (MD) and 95% CIs. In this review the authors did not identify studies in which the authors did not publish or make available the necessary information to be included in the review. For further studies identified in subsequent updates of this review, the authors will insert any data from primary studies which are not parametric (e.g. effects reported as medians, quartiles, etc) or without sufficient statistical information (e.g., SDs, number of participants, etc) into an 'Additional table'. </p> </section> <section id="CD008185-sec-0037"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis is based on the individual participant (unit to be randomised for interventions to be compared), i.e. the number of observations in the analysis should match the number of individuals randomised. The authors did not identify trials with a cross‐over design, if in subsequent updates they include such trials, they will use only first‐arm data (before participants have crossed over the treatments) (<a href="./references#CD008185-bbs2-0012" title="ElbourneDR , AltmanDG , HigginsJP , CurtinF , WorthingtonHV , VailA . Meta‐analyses involving cross‐over trials: methodological issues. International Journal of Epidemiology2002;31(1):140‐9. [PUBMED: 11914310] ">Elbourne 2002</a>). </p> </section> <section id="CD008185-sec-0038"> <h4 class="title">Dealing with missing data</h4> <p>Irrespective of the type of data, the authors reported dropout rates in the <a href="./references#CD008185-sec-0108" title="">Characteristics of included studies</a> table and they used intention‐to‐treat analysis (<a href="./references#CD008185-bbs2-0015" title="HigginsJPT , DeeksJJ , AltmanDG . Chpater 16: Special topics in statistics. Intention to treat issues. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011b</a>). </p> </section> <section id="CD008185-sec-0039"> <h4 class="title">Assessment of heterogeneity</h4> <p>As the authors only included one study they did not evaluate heterogeneity. In future updates, they will qualify inconsistency among the pooled estimates using the I<sup>2</sup> = [(Q ‐ df)/Q] x 100% test, where Q is the chi‐squared statistic and df its degrees of freedom. This illustrates the percentage of the variability in effect estimates resulting from heterogeneity rather than sampling error (<a href="./references#CD008185-bbs2-0013" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analysis. BMJ2003;327(7414):555‐7. ">Higgins 2003</a>; <a href="./references#CD008185-bbs2-0014" title="HigginsJPT , AltmanDG . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011a</a>). The thresholds for the interpretation of I<sup>2</sup> will be as follows: 0% to 25% low heterogeneity; 25% to 75% moderate heterogeneity; and more than 75% significant heterogeneity (<a href="./references#CD008185-bbs2-0013" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analysis. BMJ2003;327(7414):555‐7. ">Higgins 2003)</a>. </p> </section> <section id="CD008185-sec-0040"> <h4 class="title">Assessment of reporting biases</h4> <p>In future updates of this review, if a sufficient number of studies (at least 10) are included, the authors will assess publication bias by drawing a funnel plot (trial effect versus trial size). </p> </section> <section id="CD008185-sec-0041"> <h4 class="title">Data synthesis</h4> <section id="CD008185-sec-0042"> <h5 class="title">Qualitative information</h5> <p>The authors synthesized qualitative information relative to methods, risk of bias, description of participants and outcome measures and inserted this information in the table of <a href="./references#CD008185-sec-0108" title="">Characteristics of included studies</a>. </p> </section> <section id="CD008185-sec-0043"> <h5 class="title">Quantitative information</h5> <p>For dichotomous variables, the authors calculated the RR and 95% CIs. For continuous variables, we calculated the MD and 95% CIs. </p> <p>In subsequent updates of this review, if continuous data relate to the same outcome, but are measured with different instruments (different and not interchangeable units of measure), the authors will pool these data using the standardised mean difference (SMD). For all statistical methods when pooling data, they will report the 95% CIs. If they do not identify any significant heterogeneity, they will compute pooled estimates of the treatment effect for each outcome under a fixed‐effect model. Otherwise, if they identify significant heterogeneity, they will perform a random‐effects analysis. </p> </section> </section> <section id="CD008185-sec-0044"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>In subsequent updates of this review, If the authors find significant heterogeneity, they will investigate the possible causes of this further by exploring the impact of the condition of the individuals (i.e. severity of disease, duration of treatment). If they find sources of heterogeneity and if there are sufficient data, they will conduct meta‐analyses by subgroups (by types of dosage and duration of intervention, disease stage, age at onset). </p> </section> <section id="CD008185-sec-0045"> <h4 class="title">Sensitivity analysis</h4> <p>As only one study was included in this review, the authors did not perform any sensitivity analyses, but will do so if there are an adequate number of studies included in future updates. If, in the future, they are able to perform a sensitivity analysis, they will do so with an aim to explore possible causes of heterogeneity and the robustness of the results. </p> <p>We will include the following factors in any sensitivity analysis, separating studies according to: </p> <p> <ol id="CD008185-list-0007"> <li> <p>allocation concealment quality (low, unclear or high risk);</p> </li> <li> <p>blinding of participants, caregiver and outcome assessment (low, unclear or high risk, or not performed); </p> </li> <li> <p>rates of withdrawal for each outcome;</p> </li> <li> <p>length of follow‐up;</p> </li> <li> <p>age of participants;</p> </li> <li> <p>disease severity.</p> </li> </ol> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD008185-sec-0046" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD008185-sec-0046"></div> <section id="CD008185-sec-0047"> <h3 class="title">Description of studies</h3> <section id="CD008185-sec-0048"> <h4 class="title">Results of the search</h4> <p>There were 202 records identified by the searches: MEDLINE (PubMed): 103 references to studies; Cochrane Cystic Fibrosis and Genetic Disorders Group's Trials Register: 43 references; EMBASE: 60 references; LILACS: 3references. The authors also scrutinised the bibliographical references of these papers for further potentially eligible studies and found no additional references. After closer examination of the titles and abstracts of these references, all but eight studies were subsequently excluded from further analysis. If possible, full text copies of these remaining studies were obtained and were then subjected to further assessment. Following the verification of the whole studies, only one of them fulfilled all the inclusion criteria of this review (<a href="./references#CD008185-bbs2-0001" title="BeckM , WraithE , MuenzerJ , GiuglianiR , HarmatzP , EngCM , et al.  Long‐term weekly dosing of idursulfase in the treatment of mucopolysaccharidosis II (MPS II, Hunter syndrome) [abstract]. Journal of Inherited Metabolic Disease2007;30(Suppl 1):116. MuenzerJ , BeckM , EngCM , GiuglianiR , HarmatzP , MartinR , et al. Long‐term, open‐labeled extension study of idursulfase in the treatment of Hunter syndrome. Genetics in Medicine2011;13(2):95‐101. MuenzerJ , WraithE , BeckM , GiuglianiR , HarmatzP , EngCM , et al. Clinical benefit of enzyme replacement therapy (ERT) in mucopolysaccharidosis II (MPS II, Hunter syndrome) [abstract]. Journal of Inherited Metabolic Disease2006;29(Suppl 1):28. MuenzerJ , WraithJE , BeckM , GiuglianiR , HarmatzP , EngCM , et al. A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genetics in Medicine2006;8(8):465‐73. ">Muenzer 2006</a>) and six studies were excluded (<a href="./references#CD008185-bbs2-0003" title="MuenzerJ , CalikogluMG , ConwayAM , KimuraA . The long‐term experience of enzyme replacement therapy for Hunter syndrome (MPS II) [abstract]. Journal of Inherited Metabolic Disorder2005;28(Suppl 1):188. MuenzerJ , Gucsavas‐CalikogluM , McCandlessSE , SchuetzTJ , KimuraA . A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome). Molecular Genetics and Metabolism.2007;90(3):329‐37. MuenzerJ , TowleD , CalikogluM , McCandlessS . The 12‐month experience of enzyme replacement for mucopolysaccharidosis II (Hunter syndrome) [abstract]. Journal of Inherited Metabolic Disease2003;26(Suppl 2):144. ">Muenzer 2007</a>; <a href="./references#CD008185-bbs2-0002" title="Gutiérrez‐SolanaLG . Clinical study of enzyme replacement therapy with idursulfase. Revista de Neurologia2007;44(Suppl 1):S7‐S11. ">Gutiérrez‐Solana 2007</a>; <a href="./references#CD008185-bbs2-0007" title="Tylki‐SzymanskaA , GiuglianiR , HwuWL . A clinical trial of idursulfase in Hunter syndrome patients 5 years old and younger [abstract]. Journal of Inherited Metabolic Disease2008;31(Suppl 1):130. ">Tylki‐Szymanska 2008</a>; <a href="./references#CD008185-bbs2-0005" title="SohnYB , ChoSY , ParkSW , KimSJ , KoAR , KwonEK , et al. Phase I/II clinical trial of enzyme replacement therapy with idursulfase beta in patients with mucopolysaccharidosis II (Hunter Syndrome) [abstract]. Journal of Inherited Metabolic Disease2013;36 Suppl 2:S260, Abstract no: P‐565. [CENTRAL: 977628; CRS: 5500125000000518] SohnYB , ChoSY , ParkSW , KimSJ , KoAR , KwonEK , et al. Phase I/II clinical trial of enzyme replacement therapy with idursulfase beta in patients with mucopolysaccharidosis II (Hunter syndrome). Orphanet Journal of Rare Diseases2013;8:42. [DOI: 10.1186/1750‐1172‐8‐42] ">Sohn 2013</a>) (<a href="#CD008185-fig-0001">Figure 1</a>). An additional study is ongoing (<a href="./references#CD008185-bbs2-0008" title="NCT02055118 . A controlled, randomized, two‐arm, open‐label, assessor‐blinded, multicenter study of intrathecal idursulfase‐IT administered in conjunction with elaprase® in pediatric patients with Hunter syndrome and early cognitive impairment. https://clinicaltrials.gov/ct2/show/NCT02055118 (accessed 20 Jan 2016). ">NCT02055118</a>). </p> <div class="figure" id="CD008185-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD008185-fig-0001" src="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_n/nCD008185-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD008185-sec-0049"> <h4 class="title">Included studies</h4> <section id="CD008185-sec-0050"> <h5 class="title">Trial design</h5> <p>The included study was a multicentre, multi‐national, double‐blind, randomised, placebo‐controlled, 53‐week, phase II/III study of the efficacy and safety of idursulfase 0.5 mg/kg administered either weekly or every‐other week (EOW) in people with MPS II (<a href="./references#CD008185-bbs2-0001" title="BeckM , WraithE , MuenzerJ , GiuglianiR , HarmatzP , EngCM , et al.  Long‐term weekly dosing of idursulfase in the treatment of mucopolysaccharidosis II (MPS II, Hunter syndrome) [abstract]. Journal of Inherited Metabolic Disease2007;30(Suppl 1):116. MuenzerJ , BeckM , EngCM , GiuglianiR , HarmatzP , MartinR , et al. Long‐term, open‐labeled extension study of idursulfase in the treatment of Hunter syndrome. Genetics in Medicine2011;13(2):95‐101. MuenzerJ , WraithE , BeckM , GiuglianiR , HarmatzP , EngCM , et al. Clinical benefit of enzyme replacement therapy (ERT) in mucopolysaccharidosis II (MPS II, Hunter syndrome) [abstract]. Journal of Inherited Metabolic Disease2006;29(Suppl 1):28. MuenzerJ , WraithJE , BeckM , GiuglianiR , HarmatzP , EngCM , et al. A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genetics in Medicine2006;8(8):465‐73. ">Muenzer 2006</a>). </p> </section> <section id="CD008185-sec-0051"> <h5 class="title">Participants</h5> <p>The study included 96 people with MPS II. The biochemical evidence of MPS II included a documented deficiency in the I2S enzyme activity of less than or equal to 10% of the lower limit of the normal range measured in plasma, fibroblasts or leukocytes combined with a normal enzyme activity level of another sulfatase. All participants were required to reproducibly perform pulmonary function testing and have an abnormal FVC of less than 80% of predicted. Those individuals who had a tracheotomy or who had received a bone marrow or cord blood transplant were excluded from the study. All 96 randomised participants were male between the ages of 4.9 and 30.9 years. The mean (SD) age of participants in this study was 13.1 years (1.22), 14.4 years (1.20) and 15.1 years (1.11) for the placebo, idursulfase 0.5 mg/kg EOW and idursulfase 0.5 mg/kg weekly groups respectively. Nearly 45% of participants in the study were five to 11 years old and 25% were 19 years of age or older. There was no significant difference of age distribution among the three groups. Participants were also stratified according disease score, calculated using the baseline results of the 6MWT and the per cent predicted FVC (% predicted FVC). </p> </section> <section id="CD008185-sec-0052"> <h5 class="title">Interventions</h5> <p>The 96 participants were randomised in three groups: placebo (n = 32); idursulfase 0.5 mg/kg weekly (n = 32); and idursulfase 0.5 mg/kg EOW (n = 32). Infusions were given over a three‐hour period and participants were discharged one hour after completing each infusion provided that they remained clinically stable. </p> </section> <section id="CD008185-sec-0053"> <h5 class="title">Outcomes</h5> <p>The primary efficacy assessment of the included study was a comparison between the placebo and weekly idursulfase group for the change from baseline to week 53 in a single, two‐component composite variable combining % predicted FVC as a measure of respiratory function and 6MWT as a measure of physical functional capacity. The change from baseline to week 53 in % predicted FVC and 6MWT for each participant was calculated. Within each parameter the changes were ranked irrespective of treatment group, with the lowest change value assigned a rank of 1, the next lowest a rank of 2, and so forth. The two‐component composite score for each participant was calculated by summing the ranks of the two individual components. The 6MWT was conducted in accordance with American Thoracic Society guidelines (<a href="./references#CD008185-bbs2-0010" title="American Thoracic Society. ATS statement: guidelines for the six‐minute walk test. American Journal of Respiratory and Critical Care Medicine2002;166(1):111‐7. ">ATS 2002</a>). The secondary efficacy outcome measurements were: passive joint range of motion (JROM); liver and spleen volume by MRI and urinary GAG levels. Data were analysed using analysis of covariance with the treatment groups and study region fitted as factors and baseline participant age and baseline disease score as covariate. All analyses were performed by intention‐to treat (ITT) and each variable was quantified as a change from the baseline value. </p> </section> </section> <section id="CD008185-sec-0054"> <h4 class="title">Excluded studies</h4> <p>A total of six studies were excluded (<a href="./references#CD008185-bbs2-0002" title="Gutiérrez‐SolanaLG . Clinical study of enzyme replacement therapy with idursulfase. Revista de Neurologia2007;44(Suppl 1):S7‐S11. ">Gutiérrez‐Solana 2007</a>; <a href="./references#CD008185-bbs2-0003" title="MuenzerJ , CalikogluMG , ConwayAM , KimuraA . The long‐term experience of enzyme replacement therapy for Hunter syndrome (MPS II) [abstract]. Journal of Inherited Metabolic Disorder2005;28(Suppl 1):188. MuenzerJ , Gucsavas‐CalikogluM , McCandlessSE , SchuetzTJ , KimuraA . A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome). Molecular Genetics and Metabolism.2007;90(3):329‐37. MuenzerJ , TowleD , CalikogluM , McCandlessS . The 12‐month experience of enzyme replacement for mucopolysaccharidosis II (Hunter syndrome) [abstract]. Journal of Inherited Metabolic Disease2003;26(Suppl 2):144. ">Muenzer 2007</a>; <a href="./references#CD008185-bbs2-0004" title="MuenzerJ , HendrikszCJ , FanZ , VijayaraghavanS , PerryV4 , SantraS , et al. A phase I/II study of intrathecal idursulfase‐IT in children with severe mucopolysaccharidosis II. Genetics in Medicine2016;18(1):73‐81. ">Muenzer 2016</a>; <a href="./references#CD008185-bbs2-0005" title="SohnYB , ChoSY , ParkSW , KimSJ , KoAR , KwonEK , et al. Phase I/II clinical trial of enzyme replacement therapy with idursulfase beta in patients with mucopolysaccharidosis II (Hunter Syndrome) [abstract]. Journal of Inherited Metabolic Disease2013;36 Suppl 2:S260, Abstract no: P‐565. [CENTRAL: 977628; CRS: 5500125000000518] SohnYB , ChoSY , ParkSW , KimSJ , KoAR , KwonEK , et al. Phase I/II clinical trial of enzyme replacement therapy with idursulfase beta in patients with mucopolysaccharidosis II (Hunter syndrome). Orphanet Journal of Rare Diseases2013;8:42. [DOI: 10.1186/1750‐1172‐8‐42] ">Sohn 2013</a>; <a href="./references#CD008185-bbs2-0006" title="SohnYB , ChoSY , LeeJ , KwunY , HuhR , JinDK . Safety and efficacy of enzyme replacement therapy with idursulfase beta in children aged younger than 6 years with Hunter syndrome. Molecular Genetics and Metabolism2015;114(2):156‐60. ">Sohn 2015</a>; <a href="./references#CD008185-bbs2-0007" title="Tylki‐SzymanskaA , GiuglianiR , HwuWL . A clinical trial of idursulfase in Hunter syndrome patients 5 years old and younger [abstract]. Journal of Inherited Metabolic Disease2008;31(Suppl 1):130. ">Tylki‐Szymanska 2008</a>). One because it was an abstract reporting partial results of an ongoing case‐series study (<a href="./references#CD008185-bbs2-0007" title="Tylki‐SzymanskaA , GiuglianiR , HwuWL . A clinical trial of idursulfase in Hunter syndrome patients 5 years old and younger [abstract]. Journal of Inherited Metabolic Disease2008;31(Suppl 1):130. ">Tylki‐Szymanska 2008</a>); one because it was a phase I/II clinical trial that evaluated safety and dosing requirements (<a href="./references#CD008185-bbs2-0003" title="MuenzerJ , CalikogluMG , ConwayAM , KimuraA . The long‐term experience of enzyme replacement therapy for Hunter syndrome (MPS II) [abstract]. Journal of Inherited Metabolic Disorder2005;28(Suppl 1):188. MuenzerJ , Gucsavas‐CalikogluM , McCandlessSE , SchuetzTJ , KimuraA . A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome). Molecular Genetics and Metabolism.2007;90(3):329‐37. MuenzerJ , TowleD , CalikogluM , McCandlessS . The 12‐month experience of enzyme replacement for mucopolysaccharidosis II (Hunter syndrome) [abstract]. Journal of Inherited Metabolic Disease2003;26(Suppl 2):144. ">Muenzer 2007</a>); one because it was a narrative review (<a href="./references#CD008185-bbs2-0002" title="Gutiérrez‐SolanaLG . Clinical study of enzyme replacement therapy with idursulfase. Revista de Neurologia2007;44(Suppl 1):S7‐S11. ">Gutiérrez‐Solana 2007</a>); and one because it was a clinical trial phase I/II comparing a new formulation of the enzyme, Idursulfase beta, in two doses with the formulation of idursulfase currently available. </p> <p>For further information, please refer to the <a href="./references#CD008185-sec-0109" title="">Characteristics of excluded studies</a> table. </p> </section> </section> <section id="CD008185-sec-0055"> <h3 class="title">Risk of bias in included studies</h3> <section id="CD008185-sec-0056"> <h4 class="title">Allocation</h4> <p>Generation of randomisation sequence was not clear in the included study and we assessed this to have an unclear risk of bias (<a href="./references#CD008185-bbs2-0001" title="BeckM , WraithE , MuenzerJ , GiuglianiR , HarmatzP , EngCM , et al.  Long‐term weekly dosing of idursulfase in the treatment of mucopolysaccharidosis II (MPS II, Hunter syndrome) [abstract]. Journal of Inherited Metabolic Disease2007;30(Suppl 1):116. MuenzerJ , BeckM , EngCM , GiuglianiR , HarmatzP , MartinR , et al. Long‐term, open‐labeled extension study of idursulfase in the treatment of Hunter syndrome. Genetics in Medicine2011;13(2):95‐101. MuenzerJ , WraithE , BeckM , GiuglianiR , HarmatzP , EngCM , et al. Clinical benefit of enzyme replacement therapy (ERT) in mucopolysaccharidosis II (MPS II, Hunter syndrome) [abstract]. Journal of Inherited Metabolic Disease2006;29(Suppl 1):28. MuenzerJ , WraithJE , BeckM , GiuglianiR , HarmatzP , EngCM , et al. A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genetics in Medicine2006;8(8):465‐73. ">Muenzer 2006</a>). Authors state that the randomisation was stratified by age and total disease score at baseline. </p> <p>Allocation concealment was not discussed in the study, which therefore has been categorized as having an unclear risk of bias. </p> </section> <section id="CD008185-sec-0057"> <h4 class="title">Blinding</h4> <p>The study was double‐blind, and all participants received weekly intravenous infusions. Participants randomised to EOW idursulfase dosing received placebo infusion during intervening weeks to maintain blinding. The primary outcome assessment was conducted by a professional who was not involved with the study. We therefore judged the study to have a low risk of bias for blinding of participants, clinicians and outcome assessors. </p> </section> <section id="CD008185-sec-0058"> <h4 class="title">Incomplete outcome data</h4> <p>Ninety‐four (97.9%) of 96 participants completed one year of treatment. The two participants, who did not complete one year of treatment, died during the study: one participant in the placebo group; and one participant in the idursulfase weekly group. Neither death was considered by the investigators to be related to the study drug and analysis was done on an intention‐to‐treat basis. We have therefore assessed this domain as having a low risk of bias. </p> </section> <section id="CD008185-sec-0059"> <h4 class="title">Selective reporting</h4> <p>There is concern about selective reporting, due to important clinical outcomes (e.g. z score of height and weight, left ventricular mass index and overnight AHI) not being evaluated and we have assessed this domain as having an unclear risk of bias. </p> </section> <section id="CD008185-sec-0060"> <h4 class="title">Other potential sources of bias</h4> <p>We believe that the study was free of other problems that could put it at a high risk of bias. </p> </section> </section> <section id="CD008185-sec-0061"> <h3 class="title" id="CD008185-sec-0061">Effects of interventions</h3> <p>In the only included study, participants were randomised into three groups, idursulfase 0.5 mg/kg weekly, EOW and placebo. To evaluate the effect of each treatment the same placebo group was presented in each subgroup in the meta‐analyses graphs. </p> <section id="CD008185-sec-0062"> <h4 class="title">Primary outcomes</h4> <section id="CD008185-sec-0063"> <h5 class="title">1. Z scores for height and weight</h5> <p>This outcome was not reported in the included study.</p> </section> <section id="CD008185-sec-0064"> <h5 class="title">2. Six‐minute walk test (6MWT)</h5> <p>Following 53 weeks of treatment, participants in the weekly idursulfase 0.5 mg/kg group demonstrated a significant improvement rate compared with placebo of the primary outcome: distance walked in six minutes (6MWT) on the basis of change from baseline, MD 37.00 (95% CI 6.52 to 67.48). The EOW idursulfase 0.5 mg/kg group also showed an improvement but this was not significant compared with placebo, MD 23.00 (95% CI ‐4.49 to 50.49) (<a href="./references#CD008185-fig-0003" title="">Analysis 1.1</a>) (<a href="#CD008185-fig-0002">Figure 2</a>). </p> <div class="figure" id="CD008185-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Idursulfase 0.5 mg/kg versus placebo, outcome: 1.1 Primary outcome: Six‐minute walk test (6MWT)." data-id="CD008185-fig-0002" src="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_n/nCD008185-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Idursulfase 0.5 mg/kg versus placebo, outcome: 1.1 Primary outcome: Six‐minute walk test (6MWT). </p> </div> </div> </div> </section> </section> <section id="CD008185-sec-0065"> <h4 class="title">Secondary outcomes</h4> <section id="CD008185-sec-0066"> <h5 class="title">1. Lung function</h5> <section id="CD008185-sec-0067"> <h6 class="title">a. FEV<sub>1</sub> </h6> <p>This outcome was not reported in the included study.</p> </section> <section id="CD008185-sec-0068"> <h6 class="title">b. FVC</h6> <p>Changes from baseline in % predicted FVC and absolute FVC were reported (<a href="./references#CD008185-bbs2-0001" title="BeckM , WraithE , MuenzerJ , GiuglianiR , HarmatzP , EngCM , et al.  Long‐term weekly dosing of idursulfase in the treatment of mucopolysaccharidosis II (MPS II, Hunter syndrome) [abstract]. Journal of Inherited Metabolic Disease2007;30(Suppl 1):116. MuenzerJ , BeckM , EngCM , GiuglianiR , HarmatzP , MartinR , et al. Long‐term, open‐labeled extension study of idursulfase in the treatment of Hunter syndrome. Genetics in Medicine2011;13(2):95‐101. MuenzerJ , WraithE , BeckM , GiuglianiR , HarmatzP , EngCM , et al. Clinical benefit of enzyme replacement therapy (ERT) in mucopolysaccharidosis II (MPS II, Hunter syndrome) [abstract]. Journal of Inherited Metabolic Disease2006;29(Suppl 1):28. MuenzerJ , WraithJE , BeckM , GiuglianiR , HarmatzP , EngCM , et al. A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genetics in Medicine2006;8(8):465‐73. ">Muenzer 2006</a>). After 53 weeks, there was no statistical significance difference in % predicted FVC between the weekly idursulfase group and the placebo group, MD 2.70 (95% CI ‐2.12 to 7.52) or in the EOW idursulfase group compared with placebo group, MD ‐0.75 (95% CI ‐4.98 to 3.49) (<a href="./references#CD008185-fig-0004" title="">Analysis 1.2</a>). </p> <p>Absolute FVC was significantly increased from baseline in the weekly dosing group compared to placebo, MD 0.16 (95% CI 0.05 to 0.27) after 53 weeks. No difference was observed in absolute FVC between the EOW idursulfase group and placebo, MD 0.01 (95% CI ‐0.07 to 0.09) (<a href="./references#CD008185-fig-0005" title="">Analysis 1.3</a>). </p> </section> <section id="CD008185-sec-0069"> <h6 class="title">c. Any other measure of lung function</h6> <p>No other measure of lug function was reported in the included study.</p> </section> </section> <section id="CD008185-sec-0070"> <h5 class="title">2. Overnight apnea‐hypopnea index (AHI)</h5> <p>This outcome was not reported in the included study.</p> </section> <section id="CD008185-sec-0071"> <h5 class="title">3. Left ventricular mass index</h5> <p>This outcome was not reported in the included study.</p> </section> <section id="CD008185-sec-0072"> <h5 class="title">4. Joint mobility score</h5> <p>The included study measured changes in passive joint range of motion (JROM) (<a href="./references#CD008185-bbs2-0001" title="BeckM , WraithE , MuenzerJ , GiuglianiR , HarmatzP , EngCM , et al.  Long‐term weekly dosing of idursulfase in the treatment of mucopolysaccharidosis II (MPS II, Hunter syndrome) [abstract]. Journal of Inherited Metabolic Disease2007;30(Suppl 1):116. MuenzerJ , BeckM , EngCM , GiuglianiR , HarmatzP , MartinR , et al. Long‐term, open‐labeled extension study of idursulfase in the treatment of Hunter syndrome. Genetics in Medicine2011;13(2):95‐101. MuenzerJ , WraithE , BeckM , GiuglianiR , HarmatzP , EngCM , et al. Clinical benefit of enzyme replacement therapy (ERT) in mucopolysaccharidosis II (MPS II, Hunter syndrome) [abstract]. Journal of Inherited Metabolic Disease2006;29(Suppl 1):28. MuenzerJ , WraithJE , BeckM , GiuglianiR , HarmatzP , EngCM , et al. A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genetics in Medicine2006;8(8):465‐73. ">Muenzer 2006</a>). The authors reported that there were no significant differences between treatment groups but the values observed were not published. </p> </section> <section id="CD008185-sec-0073"> <h5 class="title">5. Liver and spleen volume</h5> <p>The study reported changes from baseline in the liver and spleen volume determined by magnetic resonance imaging (MRI) using the same imaging protocol at all sites (<a href="./references#CD008185-bbs2-0001" title="BeckM , WraithE , MuenzerJ , GiuglianiR , HarmatzP , EngCM , et al.  Long‐term weekly dosing of idursulfase in the treatment of mucopolysaccharidosis II (MPS II, Hunter syndrome) [abstract]. Journal of Inherited Metabolic Disease2007;30(Suppl 1):116. MuenzerJ , BeckM , EngCM , GiuglianiR , HarmatzP , MartinR , et al. Long‐term, open‐labeled extension study of idursulfase in the treatment of Hunter syndrome. Genetics in Medicine2011;13(2):95‐101. MuenzerJ , WraithE , BeckM , GiuglianiR , HarmatzP , EngCM , et al. Clinical benefit of enzyme replacement therapy (ERT) in mucopolysaccharidosis II (MPS II, Hunter syndrome) [abstract]. Journal of Inherited Metabolic Disease2006;29(Suppl 1):28. MuenzerJ , WraithJE , BeckM , GiuglianiR , HarmatzP , EngCM , et al. A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genetics in Medicine2006;8(8):465‐73. ">Muenzer 2006</a>). After 53 weeks, in the ITT population, liver volume changed statistically significantly in both idursulfase treatment groups (weekly and EOW) compared with the change in the placebo group, MD ‐24.50 (95% CI ‐28.94 to ‐20.06) and MD ‐23.20 (95% CI ‐27.78 to ‐18.62) respectively (<a href="./references#CD008185-fig-0007" title="">Analysis 1.5)</a>. </p> <p>After 53 weeks in the ITT population, spleen volume were significantly reduced in the idursulfase groups compared to placebo, MD ‐32.30 (95% IC ‐41.79 to ‐22.81) in the weekly group; MD ‐27.00 (95% IC ‐37.35 to ‐16.65) in the idursulfase EOW group (<a href="./references#CD008185-fig-0008" title="">Analysis 1.6</a>). </p> </section> <section id="CD008185-sec-0074"> <h5 class="title">6. Quality of life</h5> <p>This outcome was not reported in the included study.</p> </section> <section id="CD008185-sec-0075"> <h5 class="title">7. Pain</h5> <p>This outcome was not reported in the included study.</p> </section> <section id="CD008185-sec-0076"> <h5 class="title">8. Rate of hospitalizations</h5> <p>This outcome was not reported in the included study.</p> </section> <section id="CD008185-sec-0077"> <h5 class="title">9. Resources required for home care support</h5> <p>This outcome was not reported in the included study.</p> </section> <section id="CD008185-sec-0078"> <h5 class="title">10. Changes in glycosaminoglycans (GAGs) urinary excretion</h5> <p>Changes from baseline in the GAGs urinary excretion were measured in the included study (<a href="./references#CD008185-bbs2-0001" title="BeckM , WraithE , MuenzerJ , GiuglianiR , HarmatzP , EngCM , et al.  Long‐term weekly dosing of idursulfase in the treatment of mucopolysaccharidosis II (MPS II, Hunter syndrome) [abstract]. Journal of Inherited Metabolic Disease2007;30(Suppl 1):116. MuenzerJ , BeckM , EngCM , GiuglianiR , HarmatzP , MartinR , et al. Long‐term, open‐labeled extension study of idursulfase in the treatment of Hunter syndrome. Genetics in Medicine2011;13(2):95‐101. MuenzerJ , WraithE , BeckM , GiuglianiR , HarmatzP , EngCM , et al. Clinical benefit of enzyme replacement therapy (ERT) in mucopolysaccharidosis II (MPS II, Hunter syndrome) [abstract]. Journal of Inherited Metabolic Disease2006;29(Suppl 1):28. MuenzerJ , WraithJE , BeckM , GiuglianiR , HarmatzP , EngCM , et al. A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genetics in Medicine2006;8(8):465‐73. ">Muenzer 2006</a>). Urine GAGs levels decreased in participants treated with either dosing regimen of idursulfase and did not change significantly in participants treated with placebo. At week 53, the changes in the GAGs levels in the idursulfase groups (weekly and EOW) were significantly different than that of the placebo group, MD ‐207.40 (95% CI ‐284.85 to ‐129.95) and MD ‐173.20 (95% CI ‐240 to ‐105.56) respectively (<a href="./references#CD008185-fig-0009" title="">Analysis 1.7</a>). </p> </section> <section id="CD008185-sec-0079"> <h5 class="title">11. Developmental score</h5> <p>This outcome was not reported in the included study.</p> </section> <section id="CD008185-sec-0080"> <h5 class="title">12. Audiologic assessment</h5> <p>This outcome was not reported in the included study.</p> </section> <section id="CD008185-sec-0081"> <h5 class="title">13. Age at death</h5> <p>Two deaths occurred during the study (<a href="./references#CD008185-bbs2-0001" title="BeckM , WraithE , MuenzerJ , GiuglianiR , HarmatzP , EngCM , et al.  Long‐term weekly dosing of idursulfase in the treatment of mucopolysaccharidosis II (MPS II, Hunter syndrome) [abstract]. Journal of Inherited Metabolic Disease2007;30(Suppl 1):116. MuenzerJ , BeckM , EngCM , GiuglianiR , HarmatzP , MartinR , et al. Long‐term, open‐labeled extension study of idursulfase in the treatment of Hunter syndrome. Genetics in Medicine2011;13(2):95‐101. MuenzerJ , WraithE , BeckM , GiuglianiR , HarmatzP , EngCM , et al. Clinical benefit of enzyme replacement therapy (ERT) in mucopolysaccharidosis II (MPS II, Hunter syndrome) [abstract]. Journal of Inherited Metabolic Disease2006;29(Suppl 1):28. MuenzerJ , WraithJE , BeckM , GiuglianiR , HarmatzP , EngCM , et al. A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genetics in Medicine2006;8(8):465‐73. ">Muenzer 2006</a>). A 24‐year‐old male in the idursulfase weekly group developed a pulmonary infection, respiratory insufficiency and had a cardiac arrest five days after his first infusion, and he experienced a fatal cardiac arrest seven days later. A second participant, a six‐year‐old male, who was randomised to placebo developed streptococcus pneumonia following his 34<sup>th</sup> dose of blinded‐study medication, and suffered a lung haemorrhage followed by a fatal cardiac arrest eight days later. The study investigator did not consider either death as being related to the study medication. </p> </section> <section id="CD008185-sec-0082"> <h5 class="title">14. Adverse effects and toxicity of treatment</h5> <p>No participant was reported to withdraw from the study due to adverse effects (AE). The incidence of AEs were similar across treatment groups within the trial (<a href="./references#CD008185-bbs2-0001" title="BeckM , WraithE , MuenzerJ , GiuglianiR , HarmatzP , EngCM , et al.  Long‐term weekly dosing of idursulfase in the treatment of mucopolysaccharidosis II (MPS II, Hunter syndrome) [abstract]. Journal of Inherited Metabolic Disease2007;30(Suppl 1):116. MuenzerJ , BeckM , EngCM , GiuglianiR , HarmatzP , MartinR , et al. Long‐term, open‐labeled extension study of idursulfase in the treatment of Hunter syndrome. Genetics in Medicine2011;13(2):95‐101. MuenzerJ , WraithE , BeckM , GiuglianiR , HarmatzP , EngCM , et al. Clinical benefit of enzyme replacement therapy (ERT) in mucopolysaccharidosis II (MPS II, Hunter syndrome) [abstract]. Journal of Inherited Metabolic Disease2006;29(Suppl 1):28. MuenzerJ , WraithJE , BeckM , GiuglianiR , HarmatzP , EngCM , et al. A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genetics in Medicine2006;8(8):465‐73. ">Muenzer 2006</a>). The most frequently reported AEs during the study (with a excess incidence of at least a 9% compared with placebo in either idursulfase treated group) included headache, nasopharyngitis, abdominal pain, arthralgia and pruritus. All were considered to be consistent with those expected to be seen in an untreated MPS II population. The majority of AEs were reported as mild or moderate in severity in all groups. </p> <p>Of the AEs considered to be possibly related to idursulfase treatment, the most common were infusion‐related. An infusion‐related AE was defined as occurring within a day after the infusion began and was judged by the investigator to be possibly or probably related to study treatment. A similar number of participants in each treatment group experienced one or more infusion‐related AEs during the study, RR 1.05 (95% CI 0.74 to 1.48) in the weekly group compared to placebo and RR 1.05 (95% CI 0.74 to 1.48) in the EOW group (<a href="./references#CD008185-fig-0010" title="">Analysis 1.8</a>). The incidence of infusion‐related AEs was maximal between weeks four and 12 and decreased in all three groups thereafter. Infusion‐related AEs reported in the placebo group were similar in nature and severity to those in the idursulfase‐treated groups. No participant withdrew from the study because of infusion‐related AEs. </p> <p>A total of 49 serious adverse events (SAEs) occurred in 26 participants during the study: nine participants in the placebo group experienced a total of 18 SAEs; eight participants in the idursulfase EOW group experienced a total of 18 SAEs, RR 1.00 (95% CI 0.65 to 1.54); and nine participants in the idursulfase weekly group experienced a total of 13 SAEs, RR 0.72 (95% CI 0.43 to 1.21) (<a href="./references#CD008185-fig-0011" title="">Analysis 1.9</a>). The majority of these SAEs were considered unrelated to the blinded study medication, although three participants experienced SAEs that were considered by the investigators to be probably or possibly related to the study drug. </p> <p>Investigators detected IgG anti‐idursulfase antibodies in 15 participants (46.9%) in the idursulfase weekly group and in 15 participants (46.9%) in the idursulfase EOW group. In two participants (one from each active treatment group) IgM antibodies were found. The highest prevalence of IgG antibodies was seen at week 27 of the study, when 44.4% of the participants treated with idursulfase were antibody‐positive. After 53 weeks, 31.7% of participants in the idursulfase groups remained antibody‐positive. The reduction in urine GAG levels in antibody‐positive participants was approximately two‐thirds of that seen in antibody‐negative participants. There was no association with the presence of antibodies and AEs. </p> </section> <section id="CD008185-sec-0083"> <h5 class="title">15. Other results</h5> <section id="CD008185-sec-0084"> <h6 class="title">Composite score (% predicted FVC + 6MWT)</h6> <p>The efficacy endpoint in the trial included was change from baseline to week 53 in a two‐component composite score combining % predicted FVC as a measure of respiratory function and the 6MWT as a measure of functional capacity (<a href="./references#CD008185-bbs2-0001" title="BeckM , WraithE , MuenzerJ , GiuglianiR , HarmatzP , EngCM , et al.  Long‐term weekly dosing of idursulfase in the treatment of mucopolysaccharidosis II (MPS II, Hunter syndrome) [abstract]. Journal of Inherited Metabolic Disease2007;30(Suppl 1):116. MuenzerJ , BeckM , EngCM , GiuglianiR , HarmatzP , MartinR , et al. Long‐term, open‐labeled extension study of idursulfase in the treatment of Hunter syndrome. Genetics in Medicine2011;13(2):95‐101. MuenzerJ , WraithE , BeckM , GiuglianiR , HarmatzP , EngCM , et al. Clinical benefit of enzyme replacement therapy (ERT) in mucopolysaccharidosis II (MPS II, Hunter syndrome) [abstract]. Journal of Inherited Metabolic Disease2006;29(Suppl 1):28. MuenzerJ , WraithJE , BeckM , GiuglianiR , HarmatzP , EngCM , et al. A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genetics in Medicine2006;8(8):465‐73. ">Muenzer 2006</a>). The two‐component composite score of the idursulfase 0.5 mg/kg weekly group was significantly higher than in the placebo group in the intent‐to‐treat population, MD 18.96 (95% CI 6.28 to 31.64). A smaller difference was found for the idursulfase EOW compared to placebo groups in the intent‐to‐treat population, MD 12.86 (95% CI 0.77 to 24.95) (<a href="./references#CD008185-fig-0006" title="">Analysis 1.4</a>). The trial authors reported that the responses between the two idursulfase treatment groups were not significantly different, treatment difference being 10.84 ± 7.11, P = 0.1329). </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD008185-sec-0085" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD008185-sec-0085"></div> <section id="CD008185-sec-0086"> <h3 class="title" id="CD008185-sec-0086">Summary of main results</h3> <p>The evidence available so far are limited to only one randomised clinical trial (<a href="./references#CD008185-bbs2-0001" title="BeckM , WraithE , MuenzerJ , GiuglianiR , HarmatzP , EngCM , et al.  Long‐term weekly dosing of idursulfase in the treatment of mucopolysaccharidosis II (MPS II, Hunter syndrome) [abstract]. Journal of Inherited Metabolic Disease2007;30(Suppl 1):116. MuenzerJ , BeckM , EngCM , GiuglianiR , HarmatzP , MartinR , et al. Long‐term, open‐labeled extension study of idursulfase in the treatment of Hunter syndrome. Genetics in Medicine2011;13(2):95‐101. MuenzerJ , WraithE , BeckM , GiuglianiR , HarmatzP , EngCM , et al. Clinical benefit of enzyme replacement therapy (ERT) in mucopolysaccharidosis II (MPS II, Hunter syndrome) [abstract]. Journal of Inherited Metabolic Disease2006;29(Suppl 1):28. MuenzerJ , WraithJE , BeckM , GiuglianiR , HarmatzP , EngCM , et al. A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genetics in Medicine2006;8(8):465‐73. ">Muenzer 2006</a>).The results of the study included in this review show a short‐term clinical benefit in people treated with idursulfase compared with those treated with placebo. After 53 weeks of treatment, participants in the weekly idursulfase 0.5 mg/kg group demonstrated a statistically significant improvement rate compared with placebo in the distance walked in six minutes (6MWT), mean difference (MD) 37.00 (95% CI 6.52 to 67.48). The every‐other week (EOW) group also showed improvement but not significant compared with placebo, MD 23.00 (95% CI ‐4.49 to 50.49). There was no statistically significant difference in per cent predicted forced vital capacity (FVC) between the three groups and absolute FVC was significantly increased from baseline in the weekly dosing group compared to placebo, MD 0.16 (95% CI 0.05 to 0.27). In addition, urine glycosaminoglycan (GAG) excretion and liver and spleen volumes were significantly reduced from baseline by both idursulfase dosing regimens. </p> <p>Idursulfase was generally well tolerated, and the majority of treatment‐emergent adverse events were consistent with the natural history of untreated mucopolysaccharidosis (MPS) II. The most common treatment‐related adverse events were infusion related. Idursulfase antibodies were detected in 31.7% of participants at the end of the study and were related to smaller reduction in urine GAG levels. </p> <p>It is known that controlled studies in rare diseases are difficult to be conducted and so far only results of observational studies are available or ongoing. Results from two case series studies have been published in recent years. One reports the experience of enzyme replacement therapy with idursulfase in six children under five years old (<a href="./references#CD008185-bbs2-0009" title="Alcalde‐MartínC , Muro‐TudelillaJM , Cancho‐CandelaR , Gutiérrez‐SolanaLG , Pintos‐MorellG , Martí‐HerreroM , et al. First experience of enzyme replacement therapy with idursulfase in Spanish patients with Hunter syndrome under 5 years of age: Case observations from the Hunter Outcome Survey (HOS). European Journal of Medical Genetics2010;53(6):371‐7. ">Alcade‐Martín 2010</a>). The children began treatment with a mean age of 3.6 years and were followed for a mean period of nine months. Decreased levels of urinary GAG were observed, also some improvement in the volume of the liver and spleen; in addition, joint mobility stabilized or improved during treatment. Growth rate remained normal as expected; in untreated individuals with MPS II, growth decelerates at around age four or five years. With regards to safety, only mild drug‐related infusion reactions were noted. The second study assessed the overall result of enzyme replacement therapy on the growth of 18 participants (nine under 10 years of age and nine over) followed for more than three years (<a href="./references#CD008185-bbs2-0024" title="Schulze‐FrenkingG , JonesSA , RobertsJ , BeckM , WraithJE . Effects of enzyme replacement therapy on growth in patients with mucopolysaccharidosis type II. Journal of Inherited Metabolic Disease2011;34(1):203‐8. ">Schulze‐Frenking 2011</a>). All children under 10 years of age (except one who had short stature at baseline) grew at normal rate during this period. Those over 10 years of age also showed an increase in growth rate in the first two years of treatment, which decreased in the third year. The authors suggested this may be due to puberty. This study indicates that therapy may have a positive effect on growth rate especially when initiated before 10 years of age. In the latest searches undertaken for the update of this review, a further observational study was identified (<a href="./references#CD008185-bbs2-0017" title="JonesSA , PariniR , HarmatzP , GiuglianiR , FangJ , MendelsohnNJ , et al. The effect of idursulfase on growth in patients with Hunter syndrome: data from the Hunter Outcome Survey (HOS). Molecular Genetics and Metabolism2013;109(1):41‐8. ">Jones 2013</a>). The study investigated the effects of enzyme replacement therapy with idursulfase on growth in people with MPS II enrolled in the the Hunter Outcome Survey (HOS), a multinational database. A total of 133 people (8 to 15 years of age at treatment start) with data on height available on more than one occasion within 24 months of treatment start were included. Results showed that the growth velocity after treatment was significantly improved compared with before treatment. Analysis of a covariate showed a significant negative influence on growth of mutation type (individuals with deletions or large rearrangements or nonsense mutations) and age (12 to 15 years). Cognitive involvement, pubertal status and functional classification were found not be be related to the growth deficit or response to treatment. </p> <p>It is noteworthy that in the Schulze‐Frenking study one child younger than 10 years of age, who already had short stature at baseline, showed poor response in growth rate with treatment. The study authors suggested that this may be related to the development of antibodies (<a href="./references#CD008185-bbs2-0024" title="Schulze‐FrenkingG , JonesSA , RobertsJ , BeckM , WraithJE . Effects of enzyme replacement therapy on growth in patients with mucopolysaccharidosis type II. Journal of Inherited Metabolic Disease2011;34(1):203‐8. ">Schulze‐Frenking 2011</a>). The study does not provide more data on safety and the proportion of individuals who developed antibodies. From an immunological perspective, the effect of neutralizing antibodies on efficacy is still to be fully evaluated; therefore, no firm conclusions can be drawn about the effect of neutralizing activity on the safety and efficacy of idursulfase.This factor should be carefully evaluated in other studies with long‐term follow‐up, </p> <p>While enzyme replacement therapy with idursulfase has been shown to have biologic effects and may improve the functional capacity in people with MPS II, the clinical significance of these effects is not clear. The treatment improves the distance walked in six minutes (6MWD) but the average improvement is small with wide confidence intervals. Idursulfase has not been shown to improve clinically relevant outcomes such as quality of life, pain, rate of hospitalisation, resources required for home care support and mortality. </p> </section> <section id="CD008185-sec-0087"> <h3 class="title" id="CD008185-sec-0087">Overall completeness and applicability of evidence</h3> <p>The included study provided data on the efficacy and safety of short‐term (53 weeks) enzyme replacement therapy with idursulfase for people with MPS II (aged five to 31 years). The results of the open‐label extension study have recently been published (<a href="./references#CD008185-bbs2-0021" title="MuenzerJ , BeckM , EngCM , GiuglianiR , HarmatzP , MartinR , et al. Long‐term, open‐labeled extension study of idursulfase in the treatment of Hunter syndrome. Genetics in Medicine2011;13(2):95‐101. ">Muenzer 2011</a>). All individuals who completed the double‐blinded study received idursulfase 0.5 mg/kg weekly for two years. There were no improvements in the per cent predicted FVC, only in the absolute FVC, which probably reflected the growth that has occurred in those younger than 18 years of age during treatment, since this increase was not observed in those aged over 18 years. Increases in the 6MWT remained stable and mean liver and spleen volumes remained reduced. Mean joint range of motion improved only for the shoulder joint. All participants experienced adverse effects, with 59.6% experiencing at least one drug‐related adverse effect, 53% an infusion‐related adverse effect, 28.7% at least one severe or life‐threatening adverse effect. Neutralizing IgG antibodies were detected in 27.1% of the participants at the end of the extension study and seemed to attenuate the improvement in pulmonary function. Participants in the study had to be able to follow instructions and perform the test of the primary endpoint (6MWT and per cent predicted FVC) which suggests that the individuals included were not representative of those with advanced forms of the disease. The drug may achieve improvement of the physical condition, a decrease of organomegaly and urinary excretion of GAGs, but the overall benefit should be evaluated according to global somatic involvement, overall rate of disease progression in central nervous system and on variables such as improved length of survival. </p> </section> <section id="CD008185-sec-0088"> <h3 class="title" id="CD008185-sec-0088">Quality of the evidence</h3> <p>The quality of the included study was considered good, although we note the absence within the study report of information as to how both the allocation generation and concealment were performed. </p> </section> <section id="CD008185-sec-0089"> <h3 class="title" id="CD008185-sec-0089">Potential biases in the review process</h3> <p>There is concern about selective reporting, due to important clinical outcomes (e.g. growth velocity, left ventricular mass index and overnight apnoea‐hypopnoea index not being evaluated in the included study. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD008185-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/urn:x-wiley:14651858:media:CD008185:CD008185-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_t/tCD008185-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD008185-fig-0001" src="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_n/nCD008185-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/full#CD008185-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_n/nCD008185-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008185-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/urn:x-wiley:14651858:media:CD008185:CD008185-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_t/tCD008185-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Idursulfase 0.5 mg/kg versus placebo, outcome: 1.1 Primary outcome: Six‐minute walk test (6MWT)." data-id="CD008185-fig-0002" src="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_n/nCD008185-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Idursulfase 0.5 mg/kg versus placebo, outcome: 1.1 Primary outcome: Six‐minute walk test (6MWT). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/full#CD008185-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_n/nCD008185-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008185-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/urn:x-wiley:14651858:media:CD008185:CD008185-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_t/tCD008185-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Idursulfase 0.5 mg/kg versus placebo, Outcome 1 Six‐minute walk test (6MWT) (53 weeks)." data-id="CD008185-fig-0003" src="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_n/nCD008185-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Idursulfase 0.5 mg/kg versus placebo, Outcome 1 Six‐minute walk test (6MWT) (53 weeks). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/references#CD008185-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_n/nCD008185-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008185-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/urn:x-wiley:14651858:media:CD008185:CD008185-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_t/tCD008185-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Idursulfase 0.5 mg/kg versus placebo, Outcome 2 % predicted FVC (53 weeks)." data-id="CD008185-fig-0004" src="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_n/nCD008185-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Idursulfase 0.5 mg/kg versus placebo, Outcome 2 % predicted FVC (53 weeks).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/references#CD008185-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_n/nCD008185-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008185-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/urn:x-wiley:14651858:media:CD008185:CD008185-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_t/tCD008185-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Idursulfase 0.5 mg/kg versus placebo, Outcome 3 Absolute FVC (L) (53 weeks)." data-id="CD008185-fig-0005" src="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_n/nCD008185-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Idursulfase 0.5 mg/kg versus placebo, Outcome 3 Absolute FVC (L) (53 weeks). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/references#CD008185-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_n/nCD008185-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008185-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/urn:x-wiley:14651858:media:CD008185:CD008185-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_t/tCD008185-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Idursulfase 0.5 mg/kg versus placebo, Outcome 4 6MWT+ % predicted FVC (composite score) (53 weeks)." data-id="CD008185-fig-0006" src="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_n/nCD008185-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Idursulfase 0.5 mg/kg versus placebo, Outcome 4 6MWT+ % predicted FVC (composite score) (53 weeks). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/references#CD008185-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_n/nCD008185-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008185-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/urn:x-wiley:14651858:media:CD008185:CD008185-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_t/tCD008185-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Idursulfase 0.5 mg/kg versus placebo, Outcome 5 Liver volume (%) (53 weeks)." data-id="CD008185-fig-0007" src="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_n/nCD008185-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Idursulfase 0.5 mg/kg versus placebo, Outcome 5 Liver volume (%) (53 weeks). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/references#CD008185-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_n/nCD008185-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008185-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/urn:x-wiley:14651858:media:CD008185:CD008185-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_t/tCD008185-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Idursulfase 0.5 mg/kg versus placebo, Outcome 6 Spleen volume (%) (53 weeks)." data-id="CD008185-fig-0008" src="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_n/nCD008185-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Idursulfase 0.5 mg/kg versus placebo, Outcome 6 Spleen volume (%) (53 weeks). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/references#CD008185-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_n/nCD008185-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008185-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/urn:x-wiley:14651858:media:CD008185:CD008185-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_t/tCD008185-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Idursulfase 0.5 mg/kg versus placebo, Outcome 7 Urine GAG μg/mg creatinine (%)(53 weeks)." data-id="CD008185-fig-0009" src="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_n/nCD008185-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Idursulfase 0.5 mg/kg versus placebo, Outcome 7 Urine GAG μg/mg creatinine (%)(53 weeks). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/references#CD008185-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_n/nCD008185-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008185-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/urn:x-wiley:14651858:media:CD008185:CD008185-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_t/tCD008185-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Idursulfase 0.5 mg/kg versus placebo, Outcome 8 One or more infusion‐related adverse events." data-id="CD008185-fig-0010" src="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_n/nCD008185-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Idursulfase 0.5 mg/kg versus placebo, Outcome 8 One or more infusion‐related adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/references#CD008185-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_n/nCD008185-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008185-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/urn:x-wiley:14651858:media:CD008185:CD008185-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_t/tCD008185-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Idursulfase 0.5 mg/kg versus placebo, Outcome 9 Serious adverse events." data-id="CD008185-fig-0011" src="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_n/nCD008185-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Idursulfase 0.5 mg/kg versus placebo, Outcome 9 Serious adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/references#CD008185-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/media/CDSR/CD008185/image_n/nCD008185-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="comparison" data-id="CD008185-tbl-0001"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Idursulfase 0.5 mg/kg versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Six‐minute walk test (6MWT) (53 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Idursulfase 0.5 mg/kg weekly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Idursulfase 0.5 mg/kg EOW</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 % predicted FVC (53 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Idursulfase 0.5 mg/kg weekly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Idursulfase 0.5 mg/kg EOW</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Absolute FVC (L) (53 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Idursulfase 0.5 mg/kg weekly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Idursulfase 0.5 mg/kg EOW</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 6MWT+ % predicted FVC (composite score) (53 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Idursulfase 0.5 mg/kg weekly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Idursulfase 0.5 mg/kg EOW</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Liver volume (%) (53 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Idursulfase 0.5 mg/kg weekly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Idursulfase 0.5 mg/kg EOW</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Spleen volume (%) (53 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Idursulfase 0.5 mg/kg weekly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Idursulfase 0.5 mg/kg EOW</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Urine GAG μg/mg creatinine (%)(53 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Idursulfase 0.5 mg/kg weekly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Idursulfase 0.5 mg/kg EOW</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 One or more infusion‐related adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Idursulfase 0.5 mg/kg weekly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Idursulfase 0.5 mg/kg EOW</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Idursulfase 0.5 mg/kg weekly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Idursulfase 0.5 mg/kg EOW</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Idursulfase 0.5 mg/kg versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008185.pub4/references#CD008185-tbl-0001">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD008185.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD008185-note-0002">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD008185-note-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD008185-note-0001">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD008185-note-0003">Bahasa Malaysia</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br/> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008185\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008185\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008185\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008185\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008185\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008185\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008185\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008185\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008185\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008185\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008185\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008185\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008185\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008185\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008185\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008185\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008185\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008185\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=VXKc2U6b&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008185.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD008185.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD008185.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD008185.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008185.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740716331053"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD008185.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740716331057"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD008185.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d9ce84e329368',t:'MTc0MDcxNjMzMS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 